Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04693806 · ClinicalTrials.gov registry record · NA
The Effect of Embryo Culture Under a Continuous CO2 Setting Versus a Sequential CO2 Setting
A NA study, sponsored by Reproductive Medicine Associates of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 102
- Enrollment target
NCT04693806 is a NA study that has completed, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 102 participants.
The verdict
NCT04693806, a NA study, has completed, sponsored by Reproductive Medicine Associates of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 102 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if embryo culture under a single CO2 setting improves blastocyst formation rate.
Interventions
- OTHER Continuous CO2 Level
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2020-12-03 |
| Est. Completion | 2022-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04693806
The ClinicalTrials.gov registry entry for NCT04693806 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Reproductive Medicine Associates of New Jersey, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Continuous CO2 Level is the first listed.
NCT04693806 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04693806 about?
NCT04693806 is a clinical study titled "The Effect of Embryo Culture Under a Continuous CO2 Setting Versus a Sequential CO2 Setting". The purpose of this study is to determine if embryo culture under a single CO2 setting improves blastocyst formation rate.
What is the current status of trial NCT04693806?
This trial is currently completed. It is a NA study. The enrollment target is 102 participants. The study started on 2020-12-03. Estimated completion is 2022-04-30.
What interventions are being tested in trial NCT04693806?
The interventions under investigation include: Continuous CO2 Level (OTHER).
Who is sponsoring clinical trial NCT04693806?
This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.